Now showing items 1-3 of 3

    • The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design. 

      Dimairo, M; Pallmann, P; Wason, J; Todd, S; Jaki, T; Julious, SA; Mander, AP; Weir, CJ; Koenig, F; Walton, MK; Nicholl, JP; Coates, E; Biggs, K; Hamasaki, T; Proschan, MA; Scott, JA; Ando, Y; Hind, D; Altman, DG; ACE Consensus Group (2020-06-17)
      Adaptive designs (ADs) allow pre-planned changes to an ongoing trial without compromising the validity of conclusions and it is essential to distinguish pre-planned from unplanned changes that may also occur. The reporting ...
    • Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer. 

      Sumanasuriya, S; Omlin, A; Armstrong, A; Attard, G; Chi, KN; Bevan, CL; Shibakawa, A; IJzerman, MJ; De Laere, B; Lolkema, M; Lorente, D; Luo, J; Mehra, N; Olmos, D; Scher, H; Soule, H; Stoecklein, NH; Terstappen, LWMM; Waugh, D; de Bono, JS (2018-06)
      Context In advanced prostate cancer (PC), there is increasing investigation of circulating biomarkers, including quantitation and characterization of circulating tumour cells and cell-free nucleic acids, for therapeutic ...
    • Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome. 

      Fisher, BA; Jonsson, R; Daniels, T; Bombardieri, M; Brown, RM; Morgan, P; Bombardieri, S; Ng, W-F; Tzioufas, AG; Vitali, C; Shirlaw, P; Haacke, E; Costa, S; Bootsma, H; Devauchelle-Pensec, V; Radstake, TR; Mariette, X; Richards, A; Stack, R; Bowman, SJ; Barone, F; Sjögren's histopathology workshop group (appendix) from ESSENTIAL (EULAR Sjögren's syndrome study group)
      Labial salivary gland (LSG) biopsy is used in the classification of primary Sjögren's syndrome (PSS) and in patient stratification in clinical trials. It may also function as a biomarker. The acquisition of tissue and ...